Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Dec 3;132(1):215–223. doi: 10.1007/s10549-011-1889-0

Table 1.

ptxBaseline demographics and clinical characteristics

Characteristic Number (%)
Total Patients Enrolled N = 41a
Age
  Mean 53
  Median 53
  18-49 16 (39)
  50-64 18 (44)
  ≥65 7 (17)
Race/Ethnicity
  White-Non-Hispanic 16 (39)
  Hispanic 10 (24.3)
  African American 13 (31.7)
  Asian 2 (4.8)
Menopausal Status
  Pre-menopausal 17 (41.5)
  Post-menopausal 22 (53.6)
  Unknown 2 (4.8)
Clinical Tumor Size
  T2 23 (56)
  T3 15 (36.5)
  T4 3 (7.3)
Clinical Node Status
  N0 23 (56)
  N1 16 (39)
  N2 2 (4.9)
Tumor Grade
  1 9 (22)
  2 12 (29)
  3 18 (44)
  Not Reported 2 (5)
Tumor Hormone Receptor Status
  ER+ and/or PR+ 35 (85)
  ER − & PR − 6 (15)
a

one patient with bilateral breast cancer